Levy Guy

CIK 00018123052 companiesGREENWICH, CT

SEC Profile

Transactions

Companies

Filings

CIK

0001812305

Recent Transactions

19 trades

Award
BioAtla, Inc.$BCAB
Common Stock
2021-09-30$28.00/sh+267,900→ 1,115,817 total
Sale
BioAtla, Inc.$BCAB
Common Stock
2021-08-24$39.65/sh−207,640→ 847,917 total
Sale
BioAtla, Inc.$BCAB
Common Stock
2021-08-24$39.65/sh−53,195→ 217,358 total
Sale
BioAtla, Inc.$BCAB
Common Stock
2021-08-24$39.65/sh−285,874→ 1,167,378 total
Sale
BioAtla, Inc.$BCAB
Common Stock
2021-06-17$39.16/sh−337,220→ 1,453,252 total
Sale
BioAtla, Inc.$BCAB
Common Stock
2021-06-17$39.16/sh−62,780→ 270,553 total
Award
BioAtla, Inc.$BCAB
Stock Option (right to buy)
2021-06-15+12,307→ 12,307 total
Conversion
BioAtla, Inc.$BCAB
Series D Convertible Preferred Stock
2020-12-18−1,790,472→ 0 total
Purchase
BioAtla, Inc.$BCAB
Common Stock
2020-12-18$18.00/sh+1,055,557→ 1,055,557 total
Purchase
BioAtla, Inc.$BCAB
Common Stock
2020-12-18$18.00/sh+333,333→ 333,333 total
Conversion
BioAtla, Inc.$BCAB
Common Stock
2020-12-18+1,790,472→ 1,790,472 total
Conversion
Lyra Therapeutics, Inc.$LYRA
Common Stock
2020-05-05+338,330→ 338,330 total
Conversion
Lyra Therapeutics, Inc.$LYRA
Common Stock
2020-05-05+104,608→ 442,948 total
Exercise of In-Money
Lyra Therapeutics, Inc.$LYRA
Common Stock
2020-05-05$8.63/sh+31,382→ 474,330 total
Sale
Lyra Therapeutics, Inc.$LYRA
Common Stock
2020-05-05$16.00/sh−16,909→ 457,421 total
Purchase
Lyra Therapeutics, Inc.$LYRA
Common Stock
2020-05-05$16.00/sh+155,000→ 155,000 total
Conversion
Lyra Therapeutics, Inc.$LYRA
Series B Convertible Preferred Stock
2020-05-05−11,666,666→ 0 total
Conversion
Lyra Therapeutics, Inc.$LYRA
Series C Convertible Preferred Stock
2020-05-05−3,607,224→ 0 total
Exercise of In-Money
Lyra Therapeutics, Inc.$LYRA
Common Stock Warrant
2020-05-05−31,382→ 0 total

Companies

Recent Filings

Address

C/O SOLEUS PRIVATE EQUITY GP I, LLC 104 FIELD POINT ROAD, 2ND FLOOR

GREENWICH, CT, 06830

View on SEC.gov